Criteria 发表于 2025-3-25 04:55:34

Submitted on: 15 August 2011.
Revised on: 26 August 2011.
Accepted on: 18 September 2011.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

NICE 发表于 2025-3-25 08:59:16

Submitted on: 15 March 2015.
Revised on: 04 April 2015.
Accepted on: 28 April 2015.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

nurture 发表于 2025-3-25 13:31:56

Submitted on: 10 July 2015.
Revised on: 11 August 2015.
Accepted on: 29 August 2015.
NEURO-ONCOLOGY

狗舍 发表于 2025-3-25 18:44:12

http://reply.papertrans.cn/3/230/22963/22963-24.png

不来 发表于 2025-3-25 21:55:14

Submitted on: 30 April 2019.
Revised on: 08 June 2019.
Accepted on: 21 June 2019.
NEURO-ONCOLOGY

exceed 发表于 2025-3-26 00:43:13

http://reply.papertrans.cn/3/230/22963/22963-26.png

ALLAY 发表于 2025-3-26 04:55:10

http://reply.papertrans.cn/3/230/22963/22963-27.png

Adenocarcinoma 发表于 2025-3-26 10:15:01

http://reply.papertrans.cn/3/230/22963/22963-28.png

dendrites 发表于 2025-3-26 16:21:50

Submitted on: 21 June 2002.
Revised on: 03 August 2002.
Accepted on: 11 August 2002.
NEURO-ONCOLOGY---OXFORD UNIV PRESS INC

为现场 发表于 2025-3-26 17:30:04

http://reply.papertrans.cn/3/230/22963/22963-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊NEURO-ONCOLOGY 2024/2025影响因子:16.406 (NEURO-ONCOLOGY) (1522-8517). (ONCOLOGY)(肿瘤学)Science Citation Index Expanded